ABS-201
Androgenetic Alopecia (Male/Female Pattern Hair Loss)
Pre-clinicalActive (Case study indicates advancement toward clinical trials)
Key Facts
Indication
Androgenetic Alopecia (Male/Female Pattern Hair Loss)
Phase
Pre-clinical
Status
Active (Case study indicates advancement toward clinical trials)
Company
About AbSci
Absci is on a mission to create better biologics for patients, faster, by unlocking novel biology with generative AI. Founded in 2011, the company has built a unique 'lab-in-the-loop' platform that iterates between generating massive proprietary datasets, training AI models for de novo design and optimization, and validating millions of designs weekly in its wet lab. With over 25 programs in its partnered and internal pipeline, including a lead candidate for androgenetic alopecia, Absci is positioning itself as a leader in the AI-driven biotherapeutics space.
View full company profile